RT @doctorRBC: Large French study of over 23k patients with either PsA or PsO showed a longer persistence (time of initi
Tweet Content
Large French study of over 23k patients with either PsA or PsO showed a longer persistence (time of initiation to discontinuation) in those who took IL-17i vs. TNFi for PsA and PsO pts. IL-17i longer than IL-12/23i in PsA pts.
@RheumNow #EULAR2022 ABST#POS0075 https://t.co/rH1g4fPUYC
Show on Archive Page
On
Display in Search Results
On
PDQ
Off